Here, we found that inhibiting PPARγ in OSCC can promote ferroptosis by upregulating HMOX1 and promoting disulfidptosis through the upregulation of SLC7A11 and the subsequent recruitment of additional cDCs and CD8+ T cells to inhibit tumor development. The gene discussed is HMOX1; the disease is neoplasm.